CYCN - Cyclerion Therapeutics, Inc.
NasdaqCM - NasdaqCM Real-time price. Currency in USD
As of 12:07PM EDT. Market open.
Stock chart is not supported by your current browser
| Previous close | 4.3500 |
| Open | 4.5984 |
| Bid | 4.3500 x 800 |
| Ask | 4.6000 x 1000 |
| Day's range | 4.3600 - 4.5984 |
| 52-week range | 3.6400 - 25.0000 |
| Volume | |
| Avg. volume | 35,175 |
| Market cap | 9.488M |
| Beta (5Y monthly) | 1.93 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -16.2800 |
| Earnings date | 11 May 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 4.00 |
ZacksCyclerion Therapeutics, Inc. (CYCN) Reports Q2 Loss, Misses Revenue Estimates
Cyclerion Therapeutics, Inc. (CYCN) delivered earnings and revenue surprises of 8.82% and 56.90%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?